Tacrolimus ointment in onychodystrophy associated with eczema [24]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 8, 2007, Pages 1137-1138

  Lee, D Y ^a   Kim, W S ^a   Lee, K J ^a   Kim, J A ^a   Park, J H ^a   Cho, H J ^a   Yang, J M ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; ECZEMA; FEMALE; FINGER NAIL; HUMAN; LETTER; NAIL DYSTROPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ECZEMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NAIL DISEASES; OINTMENTS; TACROLIMUS;

EID: 34548180372     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.02124.x     Document Type: Letter

References (5)

1. Koo JY, Fleischer AB Jr, Abramovits W et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: Results in 8000 patients. J Am Acad Dermatol 2005; 53: S195-S205.
2. Evans AV. The expanding role of topical tacrolimus in dermatology. Clin Exp Dermatol 2005; 30: 111-115.
3. Ruzicka T, Assmann T, Homey B. Tacrolimus. the drug for the turn of the millennium? Arch Dermatol 1999; 135: 574-580.
4. Belsito D, Wilson DC, Warshaw E et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol 2006; 55: 40-46.
5. Grover C, Bansal S, Nanda S, Reddy BS. Efficacy of triamcinolone acetonide in various acquired nail dystrophies. J Dermatol 2005; 32: 963-968.